Cytokinetics and Amgen expand collaboration Cytokinetics Inc. and Amgen Inc. said Wednesday that they are expanding their collaboration on a drug to treat heart failure in a deal worth at least $25 million. The development and marketing agreement ...
June 12, 2013 - Associated Press via Yahoo! News
Critical Diagnostics' Biomarker ST2 Included in the 2013 ACC/AHA Guidelines for the Management of Heart Failure SAN DIEGO, Calif.--(BUSINESS WIRE)--Critical Diagnostics announced today that the American College of Cardiology Foundation/American Heart Association Task Force jointly released its expanded clinical practice guideline for the management of patients with heart failure and has identified ST2 “not only predictive of hospitalization and death in patients with HF [heart failure] but also additive ...
June 11, 2013 - Business Wire
High School Scientists Innovate New Medical Therapies Heart attack therapies can leave patients with an elevated risk of future heart failure, but four California high school students have a solution.
June 11, 2013 - U.S.News & World Report LP via Yahoo! News